Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin (MyoPac)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00691912
Recruitment Status : Terminated (Study was stopped due because recrutation.was much slower as anticipated.)
First Posted : June 6, 2008
Last Update Posted : September 3, 2014
Information provided by (Responsible Party):
Claudia Lorenz-Schlüter, University of Magdeburg

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : December 2013